Jiangsu Nanfang Medical Market Cap ($327.37 Million)
Market Cap & Net Worth: Jiangsu Nanfang Medical (603880)
Jiangsu Nanfang Medical market cap. Jiangsu Nanfang Medical (SHG:603880) has a market capitalization of $327.37 Million (CN¥2.24 Billion) as of November 9, 2026. Listed on the SHG stock exchange, this China-based company holds position #14101 globally and #4191 in its home market, demonstrating a -1.53% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Jiangsu Nanfang Medical's stock price CN¥7.74 by its total outstanding shares 289042000 (289.04 Million). Also see 603880 cash flow metrics for how efficiently the company converts equity into cash flow.
Jiangsu Nanfang Medical Market Cap History (2017–2026)
Jiangsu Nanfang Medical market cap history from 2017 to 2026. Data shows growth from $362.70 Million to $327.37 Million (3.42% CAGR). Check Jiangsu Nanfang Medical share price for real-time trading data and today's change.
Jiangsu Nanfang Medical Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Jiangsu Nanfang Medical's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Jiangsu Nanfang Medical annual equity growth to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.44x
Jiangsu Nanfang Medical's market cap is 0.44 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $362.70 Million | $488.71 Million | $47.60 Million | 0.74x | 7.62x |
| 2018 | $220.50 Million | $479.82 Million | $39.25 Million | 0.46x | 5.62x |
| 2019 | $285.89 Million | $491.69 Million | $28.05 Million | 0.58x | 10.19x |
| 2020 | $404.84 Million | $1.07 Billion | $98.07 Million | 0.38x | 4.13x |
| 2021 | $302.84 Million | $527.44 Million | -$22.76 Million | 0.57x | N/A |
| 2022 | $262.23 Million | $545.37 Million | -$14.65 Million | 0.48x | N/A |
| 2023 | $215.29 Million | $600.10 Million | -$147.42 Million | 0.36x | N/A |
| 2024 | $183.99 Million | $602.62 Million | -$190.67 Million | 0.31x | N/A |
| 2025 | $263.50 Million | $600.51 Million | -$101.71 Million | 0.44x | N/A |
Competitor Companies of 603880 by Market Capitalization
Companies near Jiangsu Nanfang Medical in the global market cap rankings as of November 9, 2026. Also see Jiangsu Nanfang Medical balance sheet assets for a full breakdown of the balance sheet.
Key companies related to Jiangsu Nanfang Medical by market ranking:
- Intuitive Surgical Inc (NASDAQ:ISRG): Ranked #172 globally with a market cap of $132.26 Billion USD.
- EssilorLuxottica S. A. (PA:EL): Ranked #232 globally with a market cap of $104.91 Billion USD ( €89.74 Billion EUR).
- ESSILORLUXOTTICA 1/2/O.N. (F:ESLC): Ranked #413 globally with a market cap of $67.43 Billion USD ( €57.68 Billion EUR).
- HOYA CORP. ADR/ 1 O.N. (F:HYB0): Ranked #531 globally with a market cap of $50.37 Billion USD ( €43.09 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #172 | Intuitive Surgical Inc | NASDAQ:ISRG | $132.26 Billion | $452.80 |
| #232 | EssilorLuxottica S. A. | PA:EL | $104.91 Billion | €193.80 |
| #413 | ESSILORLUXOTTICA 1/2/O.N. | F:ESLC | $67.43 Billion | €96.00 |
| #531 | HOYA CORP. ADR/ 1 O.N. | F:HYB0 | $50.37 Billion | €150.00 |
Market Capitalization of Jiangsu Nanfang Medical (2017–2026)
Market capitalization of Jiangsu Nanfang Medical from 2017 to today. Between 2017 and today, Jiangsu Nanfang Medical's market cap moved from $362.70 Million to $ 327.37 Million, with a yearly change of 3.42%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥327.37 Million | +24.24% |
| 2025 | CN¥263.50 Million | +43.22% |
| 2024 | CN¥183.99 Million | -14.54% |
| 2023 | CN¥215.29 Million | -17.90% |
| 2022 | CN¥262.23 Million | -13.41% |
| 2021 | CN¥302.84 Million | -25.19% |
| 2020 | CN¥404.84 Million | +41.61% |
| 2019 | CN¥285.89 Million | +29.65% |
| 2018 | CN¥220.50 Million | -39.21% |
| 2017 | CN¥362.70 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 9th, 2026 the market cap of Jiangsu Nanfang Medical was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $327.37 Million USD |
| MoneyControl | $327.37 Million USD |
| MarketWatch | $327.37 Million USD |
| marketcap.company | $327.37 Million USD |
| Reuters | $327.37 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Jiangsu Nanfang Medical
Jiangsu Nanfang Medical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of transdermal products, medical adhesive tapes and bandages, sports protective equipment, first aid kits, nitrile gloves, and protective equipment in China and internationally. The company offers medical proof fabrics, care products, band-aids, and applications; medical w… Read more